Home › Down Syndrome › NCT01429389
Specimen Collection From Pregnant Women at Increased Risk for Fetal Aneuploidy
RecruitingObservational study
Collection of Whole Blood Specimens From Pregnant Women at Increased Risk of Fetal Chromosomal Abnormality for Use in Development of a Noninvasive Prenatal Test in the Detection of the Relative Quantity of Chromosomal Material in Circulating Cell-Free DNA Extracted From Maternal Plasma
Who can join
Ages 18 and older · Women
Full eligibility criteria
Inclusion Criteria: * pregnant between 10 and 22 weeks gestation * 18 years of age or older * provides signed and dated informed consent * subject is at increased risk for fetal aneuploidy * subject is willing to undergo a CVS and/or amniocentesis procedure for the purpose of genetic analysis * subject agrees to provide the genetic results of the invasive procedure Exclusion Criteria: * Fetal demise at time of specimen sampling * Previous sample donation under this protocol
About the study
The specimen collection is designed for the purpose of the development of a noninvasive prenatal test for T21.
Sponsor: Sequenom, Inc. · Participants: 2,000 · Started: 2011-05
Contact the study team
Official record on ClinicalTrials.gov — NCT01429389
Locations in the U.S.
Conditions
From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.